Positron Quick Ratio (POSC) starting from the second quarter 2026 to second quarter 2015, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Positron Corporation  (POSC)

Positron's Quick Ratio

POSC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Current Liabilities decreased faster than Positron's Cash & cash equivalent, this led to improvement in Positron's Quick Ratio to 0.6, above Positron Corporation average Quick Ratio.

Within Medical Equipment & Supplies industry 136 other companies have achieved higher Quick Ratio than Positron in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 2266, from total ranking in the first quarter 2026 at 2312.

Explain Quick Ratio?
How much Cash & cash equivalents POSC´s has?
What are POSC´s Current Liabilities?




POSC Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q2
(Dec 31 2024)
Q1
(Sep 30 2015)
Q3
Y / Y Current Liabilities Change -27.41 % -16.33 % -8.67 % -66.15 % 2.07 %
Y / Y Cash & cash equivalent Change 4747.05 % 1480.62 % 3090.46 % -66.44 % -96.44 %
Quick Ratio MRQ 0.6 0.57 1.05 0.08 0.01
POSC's Total Ranking # 2266 # 2312 # # #
Seq. Current Liabilities Change -9.37 % 3.46 % 163.1 % -70.58 % 4.48 %
Seq. Cash & cash equivalent Change -3.52 % -44.19 % 3510.98 % 149.29 % -68.54 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 137
Healthcare Sector # 708
Overall Market # 2266


Quick Ratio Statistics
High Average Low
1.05 0.21 0
(Dec 31 2025)   (Jun 30 2012)




Financial Statements
Positron's Current Liabilities $ 2 Millions Visit POSC's Balance sheet
Positron's Cash & cash equivalent $ 1 Millions Visit POSC's Balance sheet
Source of POSC's Sales Visit POSC's Sales by Geography


Cumulative Positron's Quick Ratio

POSC's Quick Ratio for the trailling 12 Months

POSC Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Dec 31 2024)
12 Months
(Sep 30 2015)
12 Months
Y / Y Current Liabilities TTM Growth -29.36 % -21.47 % -37.64 % -53.83 % -65.23 %
Y / Y Cash & cash equivalent TTM Growth 1225.3 % 246.09 % 86.97 % -89.56 % -90.11 %
Quick Ratio TTM 0.66 0.45 0.29 0.03 0.04
Total Ranking TTM # 4086 # 4078 # # #
Seq. Current Liabilities TTM Growth -9.55 % -5.17 % -2.37 % -15.65 % 0.56 %
Seq. Cash & cash equivalent TTM Growth 33.02 % 48.67 % 918.53 % -34.21 % -65.26 %


On the trailing twelve months basis POSC Cash & cash equivalent more than doubled by 4747.05 % in Q2 2026 year on year, while Current Liabilities decreased to $2 millions, this led to increase in in Positron's Quick Ratio to 0.66, above POSC average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 204 other companies have achieved higher Quick Ratio than Positron. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 4078 to 4086.

Explain Quick Ratio?
How much Cash & cash equivalents POSC´s has?
What are POSC´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 205
Healthcare Sector # 907
Within the Market # 4086


trailing twelve months Quick Ratio Statistics
High Average Low
0.37 0.11 0.02
(Mar 31 2026)   (Sep 30 2013)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Seastar Medical Holding Corp  1.60 $ 6.959  Millions$ 4.353  Millions
Tela Bio Inc   1.59 $ 30.424  Millions$ 19.080  Millions
Conexeu Sciences Inc   1.55 $ 1.971  Millions$ 1.272  Millions
Inogen Inc   1.49 $ 105.539  Millions$ 70.864  Millions
Dariohealth Corp   1.49 $ 14.254  Millions$ 9.578  Millions
Myomo Inc   1.45 $ 15.686  Millions$ 10.805  Millions
Envoy Medical Inc   1.43 $ 19.679  Millions$ 13.807  Millions
Nephros Inc   1.40 $ 4.697  Millions$ 3.344  Millions
Envista Holdings Corporation  1.39 $ 1,125.600  Millions$ 807.300  Millions
Medtronic Plc  1.36 $ 16,068.000  Millions$ 11,799.000  Millions
Sanara Medtech Inc   1.31 $ 16.421  Millions$ 12.494  Millions
Globus Medical Inc   1.24 $ 595.142  Millions$ 479.347  Millions
Lucid Diagnostics Inc   1.21 $ 33.404  Millions$ 27.516  Millions
Sintx Technologies Inc   1.21 $ 3.590  Millions$ 2.977  Millions
Vaso Corporation  1.17 $ 38.291  Millions$ 32.863  Millions
Koru Medical Systems Inc   1.15 $ 8.288  Millions$ 7.180  Millions
Precision Optics Corporation Inc   1.11 $ 9.841  Millions$ 8.828  Millions
Establishment Labs Holdings Inc   1.10 $ 71.157  Millions$ 64.558  Millions
Treace Medical Concepts Inc   1.10 $ 45.619  Millions$ 41.496  Millions
Resmed Inc   1.05 $ 1,469.234  Millions$ 1,395.110  Millions
Adagio Medical Holdings inc   1.02 $ 7.740  Millions$ 7.562  Millions
Plus Therapeutics Inc   1.00 $ 8.587  Millions$ 8.567  Millions
Pavmed Inc   1.00 $ 4.070  Millions$ 4.088  Millions
Sonoma Pharmaceuticals Inc   0.98 $ 5.338  Millions$ 5.447  Millions
Nuwellis Inc   0.98 $ 3.922  Millions$ 4.008  Millions
Electrocore Inc   0.97 $ 11.543  Millions$ 11.933  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  0.96 $ 10.924  Millions$ 11.366  Millions
Medline Inc   0.96 $ 2,677.000  Millions$ 2,803.000  Millions
Neuronetics Inc   0.88 $ 24.947  Millions$ 28.309  Millions
Orthopediatrics Corp  0.87 $ 45.879  Millions$ 52.852  Millions

Date modified: 2026-08-29T17:25:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.